Relationship between smoker's paradox and p2y12 receptor inhibition therapy in patients with STEMI undergoing primary PCI

Back

ESC Premium Access

Relationship between smoker's paradox and p2y12 receptor inhibition therapy in patients with STEMI undergoing primary PCI

Session: Poster session 6 - Latest on STEMI

Topic: Infarction acute phase STEMI

Speaker: Doctor S. Degrauwe (Geneva, CH)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Sophie Degrauwe

University hospitals of Geneva, Geneva (Switzerland)

1 presentation

0 follower

70 more presentations in this session

Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome

Speaker: Doctor C. Guerreiro (Vila Nova de Gaia, PT)

Access

Abstract

Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock

Speaker: Doctor H. Tolppanen (Helsinki, FI)

Access

Abstract

Slides

Pre-hospital and in-hospital mortality from myocardial infarction in Berlin

Speaker: Professor M. Stockburger (Nauen, DE)

Access

Abstract

Slides

Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry

Speaker: Doctor J. Roehnisch (Berlin, DE)

Access

Abstract

Slides

8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.

Speaker: Mr Y. Minamimoto (Yokohama, JP)

Access

Abstract

Access the full session

Poster session 6 - Latest on STEMI

Speakers: Doctor S. Degrauwe, Doctor C. Guerreiro, Doctor H. Tolppanen, Professor M. Stockburger, Doctor J. Roehnisch...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources